O
ALMS

OrbiMed’s Alumis Inc ALMS Stock Holding History

OrbiMed’s Portfolio ALMS Stock Details ALMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.1M Sell
548,163
-554,567
-50% -$13.9M 0.24% 76
2025
Q4 		$10.8M Sell
1,102,730
-823,693
-43% -$5.75M 0.22% 78
2025
Q3 		$7.69M Hold
1,926,423
– – 0.18% 80
2025
Q2 		$5.78M Buy
+1,926,423
New +$9.1M 0.14% 75

Other funds holding ALMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OrbiMed's ALMS Position: Q1 2026 in Review

OrbiMed reduced its Alumis Inc (ALMS) stake by 50% in Q1 2026, selling an estimated $13.9M and leaving 548,163 shares worth $12.1M. The position accounts for 0.24% of the portfolio, ranked #76.

OrbiMed first reported a position in ALMS in Q2 2025 and has held it in 4 quarters since. 195 funds tracked by Wall St. Rank hold ALMS as of Q1 2026.

  • OrbiMed held 548,163 shares of Alumis Inc worth $12.1M as of Q1 2026.
  • OrbiMed sold 554,567 Alumis Inc shares in Q1 2026, an estimated $13.9M.
  • Alumis Inc made up 0.24% of OrbiMed's portfolio in Q1 2026, its #76 holding.
  • OrbiMed first reported a position in Alumis Inc in Q2 2025 and has held it in 4 quarters since.
  • 195 funds tracked by Wall St. Rank held Alumis Inc as of Q1 2026.

Based on OrbiMed's 13F filing for Q1 2026, filed 15 May 2026.